1. bookVolume 70 (2020): Issue 4 (December 2020)
Journal Details
License
Format
Journal
eISSN
1820-7448
First Published
25 Mar 2014
Publication timeframe
4 times per year
Languages
English
access type Open Access

Egg White Cystatin – A Review

Published Online: 31 Dec 2020
Volume & Issue: Volume 70 (2020) - Issue 4 (December 2020)
Page range: 401 - 422
Accepted: 05 Oct 2020
Journal Details
License
Format
Journal
eISSN
1820-7448
First Published
25 Mar 2014
Publication timeframe
4 times per year
Languages
English
Abstract

Hen eggs are widely used, not only for human consumption, but also as an important material in food production and in pharmaceutical and cosmetics industry. Cystatin is a biologically active component of egg white, mostly used as an inhibitor of papain-like cysteine proteases. It was isolated from chicken egg white and has later been used in the nomenclature of structurally and functionally related proteins. Cystatins from animals, including mouse, rat, dog, cow and chicken egg white have been isolated and recently used in foodstuffs and drug administration. Cystatin has found its place and use in medicine due to its antimicrobial, antiviral and insecticidal effects, for the prevention of cerebral hemorrhage and control of cancer cell metastasis.

Keywords

1. Ochieng J, Chaudhuri G: Cystatin superfamily. J Health care poor underserved 2010, 21:51-70.10.1353/hpu.0.0257Search in Google Scholar

2. Turk V, Stoka V, Turk D: Cystatins: biochemical and structural properties, and medical relevance. Front Biosci 2008, 13:5406-5420.10.2741/3089Search in Google Scholar

3. Turk B, Turk D, Salvesen GS: Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr Pharm Des 2002, 8(18):1623-37.10.2174/1381612023394124Search in Google Scholar

4. Ni J, Abrahamson M, Zhang M, Fernandez MA, Grubb A, Su J, Yu GL, Li Y, Parmelee D, Xing L, Coleman TA, Gentz S, Thotakura R, Nguyen N, Hesselberg M, Gentz R: Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. J Biol Chem 1997, 272(16):10853-10858.10.1074/jbc.272.16.10853Search in Google Scholar

5. Sánchez A, Vázquez A: Bioactive peptides: A review. Food Qual Saf 2017, 1:29–46.10.1093/fqs/fyx006Search in Google Scholar

6. Bouglé D, Bouhallab S: Dietary bioactive peptides: Human studies. Crit Rev Food Sci Nutr 2017, 57(2):335-343.10.1080/10408398.2013.873766Search in Google Scholar

7. Sim JS, Nakai S, Guenter W: Egg Nutrition and Biotechnology. Wallingford, UK: CAB Int; 2000, 205-217.Search in Google Scholar

8. Neurath H: Evolution of proteolytic enzymes. Sci 1984, 224(4647):350-357.10.1126/science.6369538Search in Google Scholar

9. Tavano OL: Protein hydrolysis using proteases: An important tool for food biotechnology. J Mol Catal B Enzym 2013, 90:1-11.10.1016/j.molcatb.2013.01.011Search in Google Scholar

10. Cygler M, Morb JS: Proregion structure of members of the papain superfamily. modeof inhibition of enzymatic activity. Biochem 1997, 79:645-65210.1016/S0300-9084(97)83497-9Search in Google Scholar

11. Matsumoto I, Emori Y, Abe K, Arai S. Characterization of a gene family encoding cysteine proteinases of Sitophilus zeamais (maize weevil), and analysis of the protein distribution in various tissues including alimentary tract and germ cells. J Biochem 1997, 121(3):464-76.10.1093/oxfordjournals.jbchem.a0216119133615Search in Google Scholar

12. Turk V, Bode W: The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 1991, 285(2):213-219.10.1016/0014-5793(91)80804-CSearch in Google Scholar

13. Jouanin, L, Bonadé-Bottino M, Girard C, Morrot G, Giband M: Transgenic plants for insect resistance. Plant Sci 1998, 131:1-11.10.1016/S0168-9452(97)00239-2Search in Google Scholar

14. Domoney C, Welhan I, Sidebotton C: Purification and characterization of Pisum seed trypsin Inhibitors. J Exp Bot 1993, 44(261):701-709.10.1093/jxb/44.4.701Search in Google Scholar

15. Zavasnik-Bergant T: Cystatin protease inhibitors and immune functions. Front Biosci 2008, 13:4625-4637.10.2741/3028Search in Google Scholar

16. Colella R, Sakaguchi, Y, Nagase H, Bird JWC: Chicken egg white cystatin. J Biol Chem 1989, 264:17164-17117.10.1016/S0021-9258(18)71473-7Search in Google Scholar

17. Barrett AJ: The Cystatins; a new class of peptidase inhibitors. Trend Biochem Sci 1987, 12:193-196.10.1016/0968-0004(87)90092-2Search in Google Scholar

18. Arai S, Matsumoto I, Emori Y, Abe K: Plant seed cystatins and their target enzymes of endogenous and exogenous origin. J Agric Food Chem 2002, 50(22): 6612–6617.10.1021/jf020193512381160Search in Google Scholar

19. Benchabane M, Schlüter U, Vorster J, Goulet MC, Michaud D: Plant cystatins. Biochimie 2010, 92(11):1657–1666.10.1016/j.biochi.2010.06.00620558232Search in Google Scholar

20. Sato, N, Ishidoh K, Uchiyama Y, Kominami E: Molecular cloning and sequencing of cDNA for rat cystatin b. Nucleic Acids Res 1990, 18(22):669810.1093/nar/18.22.66983326432251135Search in Google Scholar

21. Magister S, Kos, J: Cystatins in immune system. J Cancer 2013, 4(1):45–56.10.7150/jca.5044356424623386904Search in Google Scholar

22. Cornwall GA, Hsia N: A new subgroup of the family 2 cystatins. Mol Cell Endocrinol 2003, 200(1-2):1–8.10.1016/S0303-7207(02)00408-2Search in Google Scholar

23. Amin F, Khan MS, Bano B: Mammalian cystatin and protagonists in brain diseases. J Biomol Struct Dyn 2020, 38(7):2171–2196.10.1080/07391102.2019.1620636Search in Google Scholar

24. Zhou L, Li-Ling J, Huang H, Ma F, Li Q: Phylogenetic analysis of vertebrate kininogen genes. Genomics 2008, 91(2):129–141.10.1016/j.ygeno.2007.10.007Search in Google Scholar

25. Lee C, Bongcam-Rudloff E, Sollner C, Jahnen-Dechent W, Claesson-Welsh L: Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein. Front Biosci-Landmrk 2009, 14:2911–2922.10.2741/3422Search in Google Scholar

26. Saitoh F, Isemura S, Sanada K, Ohnishi K: Cystatins of family II are harboring two domains which retain inhibitory activities against the proteinase. Biol Biophys Res Commun 1991, 175:1070-1075.10.1016/0006-291X(91)91674-2Search in Google Scholar

27. Brzin J, Popovic T, Drobnic-Kosorok M, Kotnik M. Turk V: Inhibitors of cysteine proteinases from potato. Biol Chem Hoppe Seyler 1988, 369:233-238.Search in Google Scholar

28. Barrett AJ, Fritz H, Grubb A, Isemura S, Javirnen M, Katunuma N, Machleidt W, Muller-Esterl W, Sasaki M, Turk V: Nomenclature and classification of the proteins homologous with the cysteine proteinase inhibitor chicken cystatin. Biochem J 1986, 236:31210.1042/bj236031211468243491603Search in Google Scholar

29. Turk B, Turk V, Turk D: Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 1997, 378:141-150.Search in Google Scholar

30. Martinez M, Santamaria ME, Diaz-Mendoza M, Arnaiz A, Carrillo L, Ortego F, Diaz I: Phytocystatins: Defense proteins against Phytophagous insects and acari. Int. J Mol Sci 2016, 17(10):1747.10.3390/ijms17101747508577427775606Search in Google Scholar

31. Pernas, M.; Sanchez-Monge, R.; Gomez, L. and Salcedo, G: A chestnut seed cystatin differentially effective against cysteine proteinases from closely related pests. Plant Mol Biol 1998, 38(6):1235-1242.10.1023/A:1006154829118Search in Google Scholar

32. Walsh, T. A. and Strickland, J. A: Proteolysis of the 85-kilodalton crystalline cysteine proteinase inhibitor from potato release functional cystatin domains. Plant Physiol 1993, 103(4):1227-1234.10.1104/pp.103.4.12271591108290629Search in Google Scholar

33. Bolter CJ: Methyl jasmonate induces papain inhibitor(s) in tomato leaves. Plant Physiol 1993, 103:1347-135.10.1104/pp.103.4.134715912512232028Search in Google Scholar

34. Abe M, Abe K, Iwabuchi K, Domoto C, Arai S: Corn cystatin I expressed in Escherichia coli: investigation of its inhibitory profile and occurrence in corn kernels. J Biochem 1994, 116 (3):488-492.10.1093/oxfordjournals.jbchem.a124551Search in Google Scholar

35. Zhao Y, Botella MA, Subramanian L, Niu X, Nielson SS, Bressan RA, Hasegawa, PM: Two wound inducible soybean cysteine proteinase inhibitors have greater insect digestive proteinase inhibitory activities then a constitutive homolog. Plant Physiol 1996, 111:1299-1306.10.1104/pp.111.4.1299Search in Google Scholar

36. Amin F, Khan MS, Bano B:. Mammalian cystatin and protagonists in brain diseases. J Biomol Struct Dyn 2020, 38(7):2171–2196.10.1080/07391102.2019.1620636Search in Google Scholar

37. Vray B, Hartmann S, Hoebeke J: Immunomodulatory properties of cystatins. Cellular and molecular life sciences: CMLS 2002, 59(9):1503–151210.1007/s00018-002-8525-4Search in Google Scholar

38. Lindahi P, Nycander M, Ylienjaryi K, Pol E, Bjork I: Characterization by rapid-kinetic and equilibrium methods of the reaction between N-terminally truncated forms of chicken cystatin and the cysteine proteinases papain and actinidin. Biochem J 1992, 286:165-17110.1042/bj2860165Search in Google Scholar

39. Henskens YMC, Veerman ECJ, Amerongen AVN: Cystatins in health and disease. Biol Chem 1996, 377:71-86.Search in Google Scholar

40. Cimerman N, Prebanda MT, Turk B, Popovic T, Dolenc I, Turk V: Interaction of cystatin C variants with papain and human cathepsins B, H, and L. J. Enz Inhibit 1999, 14:167–174.10.3109/14756369909036552Search in Google Scholar

41. Turk D, Guncar G, Podobnik M, Turk B: Revised definition of substrate binding sites of papain-like cysteine proteases. Biol Chem 1998, 379:137-147.10.1515/bchm.1998.379.2.137Search in Google Scholar

42. Mason RW, Sol-Church K, Abrahamson M: Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases. Biochem J 1998, 330:833-838.10.1042/bj3300833Search in Google Scholar

43. Nycander M, Estrada S, Mort JS, Abrahamson M, Bjork I: Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of proteinases occluding loop. FEBS. Lett 1998, 422:61-64.10.1016/S0014-5793(97)01604-9Search in Google Scholar

44. Sanders A, Jeremy Craven C, Higgins LD, Giannini S, Conroy MJ, Hounslow AM, Waltho JP, Staniforth RA: Cystatin forms a tetramer through structural rearrangement of domain-swapped dimers prior to amyloidogenesis. J Mol Biol 2004, 336(1):165-7810.1016/j.jmb.2003.12.01114741212Search in Google Scholar

45. Olsson SL, Ek B, Wilm M, Broberg S, Pask L: Bjork I. Molecular cloning and N-terminal analysis of bovine cystatin C. Identification of full-length N-terminal region. Biochem Biophys. Acta 1997, 1343:203-210.10.1016/S0167-4838(97)00110-6Search in Google Scholar

46. Auerswald EA, Nägler DK, Gross S, Assfalg-Machleidt I, Stubbs MT, Eckerskorn C, Machleidt W, Fritz H. Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B. Eur J Biochem 1996, 235(3):534-4210.1111/j.1432-1033.1996.00534.xSearch in Google Scholar

47. Salvesen G, Parkes C, Abrahamson M, Grubb A, Barrett AJ:. Human low Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. Biochem J 1986, 234:429-434.10.1042/bj2340429Search in Google Scholar

48. Sueyoshi T, Hara A, Shimada T, Kimura M, Mortia T, Kato H, Iwanaga S: Molecular interaction of bovine kininogen and its derivatives with papain. J Biochem 1988, 104:200-206.10.1093/oxfordjournals.jbchem.a122442Search in Google Scholar

49. Turk B, Stoka V, Turk V, Johansson G, Cazzulo JJ, Bjork I: High-molecular weight kininogen binds two molecules of cysteine proteinases with different rate constants. FEBS Lett 1996, 391:109-112.10.1016/0014-5793(96)00611-4Search in Google Scholar

50. Bjork I, Pol E, Raub-Segall E, Abrahamson M, Rowan DA, Mort JS: Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes. Biochem J 1994, 299:219-225.10.1042/bj2990219Search in Google Scholar

51. Illy C, Quraishi O, Wang J, Purisima E, Vernet T, Mort JS: Role of the occluding loop in cathepsin activity. J Biol Chem 1997, 272:1197-1202.10.1074/jbc.272.2.1197Search in Google Scholar

52. Baudys M, Meloun B, Gan-Erdene T, Fusek M, Mares M, Kostka V, Pohl J, Blake CCF: S-S bridges of cathepsin B and H from bovine spleen: A basis for cathepsin B model building and resulting possible functional implications for determination between exo- and endopeptiase activities among cathepsins B, H, and L. Biomed. Biochim Acta 1991, 50:569-577.Search in Google Scholar

53. Blankenvoorde MFJ, Brand HS, Henskens YMC, Veerman ECI, Nieuw Amerongen AV: Protease inhibitors in health and disease control - Medical and industrial aspects. In: Recombinant protease inhibitors in plants. Georgetown, Texas, USA: Landes Biosci 2000, 203-214.Search in Google Scholar

54. Calkins CC, Sloane BF: Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol Chem Hoppe Seyler 1995, 376(2):71-80.Search in Google Scholar

55. Fossum, K, Whitaker JR: Ficin and papain inhibitor from chicken egg white. Arch Biochem Biophys 1968, 125:367-375.10.1016/0003-9861(68)90672-3Search in Google Scholar

56. Breznik B, Mitrović A, T Lah T, Kos J: Cystatins in cancer progression: More than just cathepsin inhibitors. Biochimie 2019, 166:233–250.10.1016/j.biochi.2019.05.002Search in Google Scholar

57. Rawling ND, Barrett AJ: Evolution of proteins of the cystatin superfamily. Biochem Biophys Res Commun 1990, 118:103-109.Search in Google Scholar

58. Bezin J, Popovie T, Turk V, Brochart U, Machleidt W: Human cystatin a new protein inhibitor of cysteine proteinases. Biochem Biophys Res Commun 1984, 118:103-109.10.1016/0006-291X(84)91073-8Search in Google Scholar

59. Freije JP, Abrahamson M, Olafsson I, Velasco G, Grubb A, Lopez-Otin C: Structure and expression of the gene encoding cystatin D, a novel human cysteine proteinase inhibitor. J Biol Chem 1991, 266:20538-20543.10.1016/S0021-9258(18)54958-9Search in Google Scholar

60. Werle B, Sauckel K, Nathanson CM, Bjarnadottir M, Spiess E, Ebert W, Abrahamson M: Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders. Biol Chem 2003, 384(2): 281-287.10.1515/BC.2003.031Search in Google Scholar

61. Sotiropoulou G, Anisowicz A, Sager R: Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J. Biol Chem 1997, 272:903-910.10.1074/jbc.272.2.903Search in Google Scholar

62. Cheng T, Hitomi K, van Vlijmen-Willems IM, de Jongh GJ, Yamamoto K, Nishi K, Watts C, Reinheckel T, Schalkwijk J, Zeeuwen PL: Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification. J Biol Chem 2006, 281(23):15893–15899.10.1074/jbc.M600694200Search in Google Scholar

63. Prunk M, Perišić Nanut M, Sabotič J, Kos J. Cystatins, cysteine peptidase inhibitors, as regulators of immune cell cytotoxicity. Period Biol 2016, 118(4):353-362.10.18054/pb.v118i4.4504Search in Google Scholar

64. Gerhartz B, Engh RA, Menttele R, Eckerskom C, Torquato R, Wittmann J, Kolb HJ, Macheidt W, Fritz H, Auerswald EA: Quail cystatin: Isolation and charactrization of a new member of the cystatin family and its hypothetical interaction with cathepsin B. FEBS Lett 1997, 412:551-558.10.1016/S0014-5793(97)00806-5Search in Google Scholar

65. Mashita M., Konagaya S: Cysteine proteinase inhibitor in egg of Chum salmon. J Biochem 1991, 110(5):762-766.10.1093/oxfordjournals.jbchem.a123655Search in Google Scholar

66. Warwas M, Gburek J, Osada J, Garab K: Purification and characterization of cystatin from duck egg white. Acta Biochim Pol 1995, 42:351–356.10.18388/abp.1995_4633Search in Google Scholar

67. Naknukool S, Hayakawa S, Sun Y, Ogawa M: Structural and physicochemical characteristics of novel basic proteins isolated from duck egg white. Biosci Biotech Bioch 2008, 72(8):2082–2091.10.1271/bbb.80178Search in Google Scholar

68. Abrahamson M, Barrett AJ, Salvesen G, Grubb A: Isolation of six cysteine proteinase inhibitors from human urine. J Biol Chem 1986, 261:11282-1128910.1016/S0021-9258(18)67380-6Search in Google Scholar

69. Trziszka T, Saleh Y, Kopeć W, Siewiński M, Wesierska E: Effect of hen’s age on the level of cystatin in chicken egg white. Int J Poul Sci 2004, 3:1-8.Search in Google Scholar

70. Calkins CC, Sloane BF: Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol Chem Hoppe Seyler 1995, 376(2):71-80.Search in Google Scholar

71. Høyer-Hansen G, Blasi F, Sloane B.F: Cysteine cathepsins and cystatins as cancer biomarkers. In: Edwards D., (eds) The Cancer Degradome 2008, Springer, New York.Search in Google Scholar

72. Leto G, Crescimanno M Flandina C: On the role of cystatin C in cancer progression. Life Sci 2018, 202:152–160.10.1016/j.lfs.2018.04.01329654808Search in Google Scholar

73. Nakabayashi H, Hara M, Shimuzu K: Clinicopathologic significance of cystatin C expression in gliomas. Hum Pathol 2005, 36(9):1008-1015.10.1016/j.humpath.2005.06.02116153465Search in Google Scholar

74. Nishikawa H, Ozaki Y, Nakanishi T, Blomgren K, Tada T, Arakawa A, Suzumori K: The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer. Gynecol Oncol 2004, 92(3):881-886.10.1016/j.ygyno.2003.11.01714984956Search in Google Scholar

75. Strojan P, Aničin A, Svetic B, Šmid L, Kos J:. Proteolytic profile of cysteine proteases and inhibitors determines tumor cell phenotype in squamous cell carcinoma of the head and neck. Int. J Biol Markers 2011, 26(4):247–254.10.5301/JBM.2011.883322139645Search in Google Scholar

76. Ferguson TW, Komenda P, Tangri N: Cystatin C as a biomarker for estimating glomerular filtration rate. Curr Opin Nephrol Hypertens 2015, 24(3):295–300.10.1097/MNH.000000000000011526066476Search in Google Scholar

77. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP: Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995, 47(1):312-318.10.1038/ki.1995.407731163Search in Google Scholar

78. Kim J, Lee CM, Kim HJ: Biomarkers for chronic kidney disease in dogs: a comparison study. J Vet Med Sci 2020, 82(8):1130-1137.10.1292/jvms.20-0125746805332581150Search in Google Scholar

79. Ghys L, Paepe D, Smets P, Lefebvre H, Delanghe J, Daminet S: Cystatin C: a new renal marker and its potential use in small animal medicine. J Vet Intern Med 2014, 28(4):1152-1164.10.1111/jvim.12366485794824814357Search in Google Scholar

80. Kovarikova S: Indirect markers of glomerular filtration rate in dogs and cats: a review. Vet Med 2018, 63:395-412.10.17221/77/2017-VETMEDSearch in Google Scholar

81. Miyagawa Y, Takemura N, Hirose H: Evaluation of the measurement of serum cystatin C by an enzyme-linked immunosorbent assay for humans as a marker of the glomerular filtration rate in dogs. J Vet Med Sci 2009, 71:1169–1176.10.1292/jvms.71.116919801896Search in Google Scholar

82. Antognoni MT, Siepi D, Porciello F, Rueca F, Fruganti G: Serum cystatin-C evaluation in dogs affected by different diseases associated or not with renal insufficiency. Vet Res Commun 2007, 31(Suppl 1):269–271.10.1007/s11259-007-0044-117682892Search in Google Scholar

83. Martin C, Péchereau D, De la Farge F, Braun JP: Cystatine C plasmatique chez le chat: Les technique actuelles ne permettent pas de l’utiliser comme marqueur d’insufficance rénale. Rev Med Vet 2002, 153:305–310.Search in Google Scholar

84. Poswiatowska-Kaszczyszyn I. Usefulness of serum cystatin C measurement for assessing renal function in cats. Bull Vet Inst Pulawy 2012, 56:235–239.10.2478/v10213-012-0042-0Search in Google Scholar

85. Ghys LF, Paepe D, Lefebvre HP, Reynolds BS, Croubels S, Meyer E, Delanghe JR, Daminet S: Evaluation of cystatin C for the detection of chronic kidney disease in cats. J Vet Intern Med 2016, 30(4):1074-82.10.1111/jvim.14256510842227461722Search in Google Scholar

86. Ghys LFE, Paepe D, Taffin ERL, Vandermeulen E, Duchateau L, Smets PMY, Delanghe J, Daminet S: Serum and urinary cystatin C in cats with feline immunodeficiency virus infection and cats with hyperthyroidism. J Feline Med Surg 2016, 18(8):658-65.10.1177/1098612X1559234326101237Search in Google Scholar

87. Tizon B, Ribe EM, Mi W, Troy CM, Levy E: Cystatin C protects neuronal cells from amyloid-beta-induced toxicity. J Alzheimers Dis 2010, 19:885–894.10.3233/JAD-2010-1291288917520157244Search in Google Scholar

88. Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, Sommer J, Schmidt SD, Nixon RA, Mathews PM, Levy E: Cystatin C inhibits amyloid-beta deposition in Alzheimer’s disease mouse models. Nat Genet 2007, 39(12):1440-1442.10.1038/ng.2007.2918026100Search in Google Scholar

89. Gauthier S, Kaur G, Mi W, Tizon B, Levy E: Protective mechanisms by cystatin C in neurodegenerative diseases. Front Biosci 2011, 3:541–554.10.2741/s170303862521196395Search in Google Scholar

90. Stańczykiewicz B, Jak ubik-Witkowska M, Rutkowska M, Polan owski A, Gbur ek J, Gołąb K, Juszczyńs ka K, Trzis zka T, Rymaszews ka J : Beneficial effect of ovocystatin on the cognitive decline in APP/PS1 transgenic mice. Adv Med Sci 2019, 64(1):65-71.10.1016/j.advms.2018.08.00230504006Search in Google Scholar

91. Schelp FP, Pongpaew P: Protection against cancer through nutritionally-induced increase of endogenous proteinase inhibitors - a hypothesis. Int J Epidemiol 1988, 17(2):287-92.10.1093/ije/17.2.2872456996Search in Google Scholar

92. Bjornland K, Buo L, Kjonniksen I, Larsen M, Fodstad O, Johansen HT, Aasen AO: Cysteine proteinase inhibitors reduce malignant melanoma cell invasion in vitro. Anticancer Res 1996, 16(4A):1627-1631.Search in Google Scholar

93. Ervin H, Cox JL: Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression. Cancer Cell Int 2005, 5(1):14.10.1186/1475-2867-5-14115691815904519Search in Google Scholar

94. Xie Q, Tang N, Lin Y, Wang X, Lin X, Lin J: Recombinant adenovirus snake venom cystatin inhibits the growth, invasion, and metastasis of B16F10 cells in vitro and in vivo. Melanoma Res 2013, 23(6):444-51.10.1097/CMR.0000000000000031Search in Google Scholar

95. Ren WP, Sloane BF: Cathepsins D and B in breast cancer. Cancer Treat Res 1996, 83:325-52.10.1007/978-1-4613-1259-8_16Search in Google Scholar

96. Laurent-Matha V, Huesgen PF, Masson O, Derocq D, Prébois C, Gary-Bobo M, Lecaille F, Rebière B, Meurice G, Oréar C, Hollingsworth RE, Abrahamson M, Lalmanach G, Overall CM, Liaudet-Coopman E: Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment. FASEB J 2012, 26(12):5172-81.10.1096/fj.12-205229Search in Google Scholar

97. Lenarcic B, Kos J, Dolenc I, Lucovnik P, Krizaj I, Turk V. Cathepsin D inactivates cysteine proteinase inhibitors, cystatins. Biochem Biophys Res Commun 1988, 154(2):765-72.10.1016/0006-291X(88)90206-9Search in Google Scholar

98. Tokyol C, Köken T, Demirbas M, Dilek FH, Yörükoglu K, Mungan U, Kirkali Z: Expression of cathepsin D in bladder carcinoma: correlation with pathological features and serum cystatin C levels. Tumori 2006, 92(3):230–235.10.1177/030089160609200308Search in Google Scholar

99. Aghdassi AA, John DS, Sendler M, Weiss FU, Reinheckel T, Mayerle J, Lerch MM: Cathepsin D regulates cathepsin B activation and disease severity predominantly in inflammatory cells during experimental pancreatitis. J Biol Chem 2018, 293(3):1018–1029.10.1074/jbc.M117.814772577724429229780Search in Google Scholar

100. Berquin IM, Sloane BF: Cathepsin B expression in human tumors. Adv Exp Med Biol 1996, 389:281-29410.1007/978-1-4613-0335-0_358861022Search in Google Scholar

101. Lie MA, Loos BG, Henskens YM, Timmerman MF, Veerman EC, van der Velden U, van der Weijden GA. Salivary cystatin activity and cystatin C in natural and experimental gingivitis in smokers and non-smokers. J Clin Periodontol 2001, 28(10):979-98410.1034/j.1600-051x.2001.028010979.x11686817Search in Google Scholar

102. Buttle DJ, Bramwell H, Hollander AP: Proteolytic mechanisms of cartilage breakdown: A target for arthritis therapy? J Clin Pathol 1995, 48:167-177.10.1136/mp.48.4.M16740795616696000Search in Google Scholar

103. Požgan U, Caglič D, Rozman B, Nagase H, Turk V, Turk B: Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis, Biological Chemistry 2010, 391(5):571-579.10.1515/bc.2010.035Search in Google Scholar

104. Kobayashi H, Ohi H, Sugimura M, Shinohara H, Fujii T, Terao T: Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res 1992, 52:3610-3614.Search in Google Scholar

105. Levicar N, Kos J, Blejec A, Golouh R, Vrhovec I, Frkovic-Grazio S, Lah TT: Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients. Cancer Epidemiol 2002, 26(1):42–49.10.1016/S0361-090X(02)00015-6Search in Google Scholar

106. Schmalfeldt B, Kuhn W, Reuning U, Pache L, Dettmar P, Schmitt M, Janicke F, Hofler H, Graeff H: Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, and inhibitors types 1 and 2. Cancer Res 1995, 55:3958-3963.Search in Google Scholar

107. Keppler D, Abrahamson M, Sordat B: Secretion of cathepsin B and tumour invasion. Biochem Soc Trans 1994, 22:43-49.10.1042/bst0220043Search in Google Scholar

108. Kobayashi H, Sugino D, She MY, Ohi H, Hirashima Y, Shinohara H, Fujie M, Shibata K, Terao T: A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis. Eur J Biochem 1998, 1;253(3):817-826.10.1046/j.1432-1327.1998.2530817.xSearch in Google Scholar

109. Thomssen C, Oppelt P, Janicke F, Ulm K, Harheck N, Hofler H, Kuhn W, Graeff H, Schmitt M: Identification of low-risk node-negative breast cancer patients by tumors biological factors PAI-I and cathepsin L. Anticancer Res 1998. 18, 2173 - 2180.Search in Google Scholar

110. Saleh Y, Siewinski M, Kielan W, Ziolkowski P: Activities of cysteine proteinases cathepsin B, L and their inhibitors: regulation of cathepsin B and L expression by egg white cysteine proteinase inhibitor. J Exp Ther Oncol 2003, 3:319–324.10.1111/j.1533-869X.2003.01105.xSearch in Google Scholar

111. Verdot L, Lalmanach G, Vercruysse V, Hartmann S, Lucius R, Hoebeke J, Gauthier F, Vray B: Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. J Biol Chem 1996, 271(45):28077-28081.10.1074/jbc.271.45.28077Search in Google Scholar

112. Das L, Datta N, Bandyopadhyay S, Das PK: Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol 2001, 166(6):4020-4028.10.4049/jimmunol.166.6.4020Search in Google Scholar

113. Henskens YM, Veerman EC, Nieuw Amerongen AV.. Cystatins in health and disease. Biol Chem Hoppe Seyler 1996, 377(2):71-86Search in Google Scholar

114. Aoki H, Akaike T, Abe K, Kuroda M, Arai S, Okamura R Neji A, Maeda H: Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus type 1 in vitro and in vivo. Antimicrob Agent Chemother 1995, 39:846-849.10.1128/AAC.39.4.846Search in Google Scholar

115. Kondo H, Ijiri S, Abe K, Maeda H, Arai S: Inhibitory effect of oryzacystatins and a truncation mutant of the replication of poliovirus in infected Vero cells. FEBS Lett 1992, 299:48-50.10.1016/0014-5793(92)80097-ZSearch in Google Scholar

116. Kan Y, Okabayashi T, Yokota S, Yamamoto S, Fujii N, Yamashita T: Imiquimod suppresses propagation of herpes simplex virus 1 by upregulation of cystatin A via the adenosine receptor A1 pathway. J Virol 2012, 86(19):10338–10346.10.1128/JVI.01196-12Search in Google Scholar

117. Blankenvoorde MFJ, Henskens YMC, Van’t Hof W: Antibacterial activity against Porphyromonas gingivalis by cystatins. In: Hopsu Havu VK, Jarvinen M, Kirschke H, eds. Proteolysis in cell fuctions. Amsterdam: IOS Press. 1997, 532-539.Search in Google Scholar

118. Naito Y, Sasaki M, Umemoto T: Bacterial effect of rat cystatin S on an oral bacterium, Porphyromonas gingivalis. Comp Biochem Physiol 1995, 110:71-75.10.1016/0742-8413(94)00070-QSearch in Google Scholar

119. Grenier D: Effect of protease inhibitors on in vitro growth of Porphyromonas gingivalis. Microb Ecol Health Dis 1992, 5:133-138.10.3109/08910609209141307Search in Google Scholar

120. Takahashi M, Tezuka T, Katunuma N: Inhibition of growth and cysteine proteinase activity of Staphylococcus aureus V8 by phosphorylated cystatin A in skin cornified envelope. FEBS Lett 1994, 355:275-278.10.1016/0014-5793(94)01196-6Search in Google Scholar

121. Melo P, El Chamy Maluf S, Azevedo MF, Paschoalin T, Budu A, Bagnaresi P, Henrique-Silva F, Soares-Costa A, Gazarini ML, Carmona AK: Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4. Parasitol Int 2018, 67(2):233–236.10.1016/j.parint.2017.12.00529288140Search in Google Scholar

122. Kolaczkowska A, Kolaczkowski M, Sokolowska A, Miecznikowska H, Kubiak A, Rolka K, Polanowski A: The antifungal properties of chicken egg cystatin against Candida yeast isolates showing different levels of azole resistance. Mycoses 2010, 53(4):314–320.10.1111/j.1439-0507.2009.01722.x19549107Search in Google Scholar

123. Luaces AL, Barrett AJ: Affinity purification and biochemical characterization of histolysin, the major cysteine proteinase of Entamoeba histolytica. Biochem J 1998, 250(3):903-909.10.1042/bj250090311489412898937Search in Google Scholar

124. Wesierska, E, Saleh, Y, Trziszka, T, Kopeć W, Siewiński M, Korzekwa K. Antimicrobial activity of chicken egg white cystatin. World J Microbiol Biotechnol 2005, 21:59–64.10.1007/s11274-004-1932-ySearch in Google Scholar

125. Benjakul S, Visessanguan W, An H:. Properties of cysteine proteinase inhibitors from black gram and rice bean. J Food Chem 2001, 25:211-227.10.1111/j.1745-4514.2001.tb00735.xSearch in Google Scholar

126. Izquierdo-Pulido ML, Haard TA, Hung J, Haard NF: Oryzacystatin and other proteinase inhibitors in rice grain: potential use as a fish processing aid. J Agric Food Chem 1994, 42:616-622.10.1021/jf00039a003Search in Google Scholar

127. Singh A, Benjakul S: Proteolysis and Its Control Using Protease Inhibitors in Fish and Fish Products: A Review. Compr. Rev. Food Sci. Food Saf 2018, 17:496-509.10.1111/1541-4337.1233733350077Search in Google Scholar

128. Tzeng SS, Chen GH, Chung YC, Jiang ST: Expression of soluble form carp (Cyprinus carpio) ovarian cystatin in Escherichia coli and its purification. J Agric Food Chem 2001, 49:4224-4230.10.1021/jf010513511559115Search in Google Scholar

129. Jiang ST, Tzeng SS, Wu WT, Chen GH: Enhanced expression of chicken cystatin as a thioredoxin fusion form in Escherichia coli AD494(DE3)pLysS and its effect on the prevention of surimi gel softening. J Agric food Chem 2002, 50:3731-3737.10.1021/jf020053v12059151Search in Google Scholar

130. Jiang ST, Hsieh JF, Tsai GJ: Interactive effects of microbial transglutaminase and recombinant cystatin on the mackerel and hairtail muscle protein. J Agric Food Chem 2004, 52(11):3617–3625.10.1021/jf035102y15161240Search in Google Scholar

131. Chen GH, Tang SJ, Chen CS, Jiang ST: High-level production of recombinant chicken cystatin by Pichiapastoris and its application in mackerel surimi. J Agric Food Chem 2001, 49(2):641–646.10.1021/jf000992s11262005Search in Google Scholar

132. Szpak M, Trziszka T, Polanowski A, Gburek J, Gołąb K, Juszczyńska K, Janik P, Malicki A, Szyplik K: Evaluation of the antibacterial activity of cystatin against selected strains of Escherichia coli. Folia Biologica (Kraków), 2014, 62:187-192.10.3409/fb62_3.18725403072Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo